Buy Like Buffett

The Moat Index

Medinotec Inc.

MDNC · Healthcare · FY2026 filings · Narrow moat ·

On the watchlist

71/ 100
Narrow moat

The four filters

Pricing power84

Median gross margin 52.8% over 4y, very stable.

Returns on capital100

Median ROIC 124.8%, above the 9% hurdle in 100% of years.

Balance-sheet safety54

Net debt/EBITDA n/ax, interest coverage 12x.

Capital discipline24

Owner earnings trend unclear, share count growing (dilution).

Margin of safety

Above valueOn sale
No price data
Owner earnings (normalized)
$279902
Est. intrinsic value / share
$0.26
Recent price
—
Discount to value
No price data

Conservative model: 9% discount rate, 0% assumed growth (capped at 4%), maintenance capex ≈ min(capex, D&A).

6 years of fundamentals

The business, in plain English

Medinotec Inc. booked $9.7M of revenue in FY2026 in the Healthcare sector and kept 52.7% of it as gross profit — a solid-margin business by that measure. After every other cost, 8.2% of each revenue dollar reached the bottom line.

MDNC's filings don't disclose total debt in a form the methodology can use, so leverage is treated as unmeasured — never assumed to be zero.

Put together: Returns on Capital is the strongest of the four filters (100/100) and Capital Discipline the weakest (24/100), which is how MDNC lands at 71/100 — a Narrow moat.

This breakdown is generated from the filed numbers and sub-scores above — no outside narrative, no estimates. Where a filing doesn’t disclose an input, the sentence that would need it is omitted instead of guessed.

FY2021–FY2026 · 6 fiscal years, normalized from MDNC’s SEC filings

RevenueSales, as filed$9.7M FY2026
$0$5M$10M2021202320252026
Gross marginRevenue kept after cost of goods52.7% FY2026
0%25%50%2021202320252026
Return on invested capitalOperating profit on the capital employed37.0% FY2026
0%100%200%2021202320252026
Owner earningsCash an owner could take out$874012 FY2026
$0$1M$2M2021202320252026

Gaps in a line mean that item isn’t in MDNC’s filings for that year — the series is never interpolated or estimated. The Table view lists every filed value, including operating and net margins, total debt, and share count.

Moat Score history

1 logged reading since Jul 18, 2026 · append-only, never rewritten

Moat Score over timeLast scored reading of each day, on the 0–100 scale70.7 / 100
0406080100WideNarrowShallowNo moatJul 18, 2026

Score history begins Jul 18, 2026 — the record builds from here and can’t be backfilled.

Tier changesSame-methodology crossings of the Wide / Narrow / Shallow bars

None yet — MDNC has read Narrow moat for every logged capture since Jul 18, 2026.

Scores are logged append-only and never overwritten — this record can’t be backfilled, which is exactly why it’s worth keeping.

Track record

How Medinotec Inc.’s moat rated in each of the years we can reconstruct from its filings — scored only on what was knowable at the time — and what its price and returns did afterward. The score never saw a price; the two are joined only in hindsight, for education, not as a signal.

As-of scores 2023–2025, one methodology version · reconstructed from filings on file each Dec 31 — never with hindsight

As-of Moat Score (dot colored by tier)Indexed price (total-return (dividends reinvested))Rated Wide-moat that year

How to read this: each dot is what the engine would have scored MDNC on that December 31; the line below is its total-return price path (dividends reinvested) in the years since.

0406080100WideNarrowShallowNo moatAs-of Moat Score100Indexed price · log scale 202320242025

Two tracks, one timeline: the score has its own 0–100 scale (top), the price its own 100-based scale (bottom) — never a shared axis. The indexed price path isn't available for this company yet; gaps in the score line are years with no reconstructed rating (see the table for why). The Table view carries every value.

What followed, in the years it rated Wide

In the reconstructed history shown, MDNC did not rate Wide-moat in any year, so there is no wide-moat track record to report. That absence is itself the honest answer — we don’t manufacture a comparison where the rating never earned one.

Healthcare context

#56 of 461 scored Healthcare companies, ranked by Moat Score.

Nearest peers by Moat Score

  1. #54AATC AUTOSCOPE TECHNOLOGIES CORP71.0Narrow moat
  2. #55AMGN Amgen Inc.70.7Narrow moat
  3. #57FTLF FITLIFE BRANDS, INC.70.5Narrow moat
  4. #58MSA MSA Safety Inc70.2Narrow moat

Compare MDNC with its nearest peers →All Healthcare companies on the Index →

Common questions about MDNC

Does Medinotec Inc. have an economic moat?
Based on its FY2026 SEC filings, the Moat Index scores Medinotec Inc. (MDNC) 70.7 out of 100 — a Narrow moat. The four filters behind that score (each 0–100): pricing power 84, returns on capital 100, balance-sheet safety 54, capital discipline 24.
How has MDNC's Moat Score changed over time?
The record logs 1 reading since Jul 18, 2026; the latest reads 70.7 out of 100 (narrow moat). No tier changes on record yet. The history is append-only — readings are only ever added, never rewritten.
Embed this score on your site

One iframe, no script. The badge shows MDNC’s live Moat Score, updates itself as new filings are scored, and links back here. How it works.

<iframe
  src="https://buylikebuffett.com/embed/MDNC"
  width="340" height="150" style="border:0"
  title="MDNC Moat Score — The Moat Index"
  loading="lazy"></iframe>

Scored from primary SEC filings via the public methodology. Educational only — not a recommendation to buy or sell MDNC. See the disclaimer.

Medinotec Inc. (MDNC) Moat Score — The Moat Index · Buy Like Buffett